Zimmer
-
Extremities
Extremity Medical Files Patent Infringement Lawsuit Against Nextremity Solutions, Zimmer Biomet Holdings and Zimmer, Inc.
April 6, 2022 PARSIPPANY, N.J.–(BUSINESS WIRE)–Extremity Medical, LLC, a global medical device company focused on the development of innovative implants…
Read More » -
Hospitals
“SERIOUS“ FDA OBSERVATION AT ZIMMER BIOMET WARSAW PLANT
Walter Eisner – Wed, February 1st, 2017 Zimmer Biomet Holdings, Inc. has a lot of ‘splaining to do to the…
Read More » -
Hospitals
Zimmer Biomet Announces FDA Approval of Expanded 26-week Efficacy Claim for Gel-One® Cross-Linked Hyaluronate for Treatment of Pain Associated with Knee Osteoarthritis
WARSAW, Ind., Feb. 1, 2017 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that the U.S. Food…
Read More » -
Recon
Zimmer Biomet Announces Americas Leadership Transition
WARSAW, Ind., Jan. 17, 2017 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that…
Read More » -
Financial
Zimmer Biomet Announces Resolution with DOJ and SEC Regarding Previously Disclosed Legacy Biomet FCPA Matters
WARSAW, Ind., Jan. 12, 2017 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, announced…
Read More » -
Financial
Zimmer Biomet Announces Fourth Quarter and Full-Year 2016 Preliminary Sales Results
WARSAW, Ind., Jan. 10, 2017 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced preliminary financial results for…
Read More » -
Financial
Zimmer Biomet Announces Quarterly Dividend for Fourth Quarter of 2016
WARSAW, Ind., Dec. 19, 2016 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today…
Read More » -
Recon
National Joint Registry Analysis Finds Zimmer Biomet Trabecular Metal™ Cups Associated with Significantly Lower Risk of Subsequent Revision Due to Infection in Revision Hip Procedures
WARSAW, Ind., Dec. 14, 2016 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced…
Read More » -
Hospitals
Zimmer Biomet Update on Product Supply Matters and Responsive Statement on Recently Completed FDA Inspection
December 14, 2016 As an update to the Company’s statement published on November 8, 2016 concerning product supply matters, Zimmer…
Read More » -
Spine
Zimmer Biomet Strengthens Spine Offering with PrimaGen Advanced™ Allograft
WARSAW, Ind., Dec. 13, 2016 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced the…
Read More » -
Financial
Zimmer Biomet Announces Closing of €1 Billion Senior Notes Offering and Early Settlement of Its Cash Tender Offers for Certain Outstanding Debt Securities
WARSAW, Ind., Dec. 13, 2016 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) (the “Company”) today announced that it has completed an offering of…
Read More » -
Financial
Zimmer Biomet Named Indo UK Institutes of Health Medicities Program’s Preferred Orthopaedic Partner to Improve Delivery of Care in India
WARSAW, Ind., Nov. 22, 2016 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that the…
Read More » -
Financial
Zimmer Biomet Announces Cash Tender Offers for Up to $1.1 Billion Aggregate Purchase Price of Certain Outstanding Debt Securities
WARSAW, Ind., Nov. 21, 2016 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) (the “Company”) today announced the commencement of…
Read More » -
Recon
Zimmer Biomet Announces Launch of the Comprehensive® Vault Reconstruction System – the First Commercially Available Patient-matched Glenoid Implant
WARSAW, Ind., Nov. 17, 2016 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare,…
Read More » -
Financial
Seikagaku Announces Exclusive Distributorship Agreement in the U.S. for VISCO-3™, A Three-Injection Viscosupplement Product
November 8, 2016 Seikagaku Corporation (“Seikagaku”) (head office: Tokyo, Japan) today announced that it has entered into an exclusive distributorship…
Read More »